HB 152 Louisiana House · 2026 Regular Session

CONTROLLED SUBSTANCES: Adds certain substances to the Uniform Controlled Dangerous Substances Law (EN SEE FISC NOTE GF EX)

HB 152 adds 13 specific synthetic opioids, including various fentanyl analogs like N-Pyrrolidino metonitazene and Beta-Methylacetyl fentanyl, to Louisiana's Schedule I controlled substances list. This means these substances are now classified as illegal without a prescription, making possession or distribution a criminal offense under state law. The bill directly affects individuals who use or distribute these drugs, as they will face the same legal penalties as other Schedule I substances. The change updates Louisiana's controlled substances law to address emerging synthetic drugs identified through chemical names.

Issues: ✗ Criminal Justice

Bill status signed all 5 stages cleared

Introduction

Feb 2026

Committee Review

Apr 2026

House Passage

Mar 2026

Senate Passage

Apr 2026

Signed into Law

May 2026

Introduced Feb 13, 2026 Signed May 11, 2026

Maddy AI version diff · 3 comparisons

What changed between versions

HB152 Original → HB152 Act · 3 edits

MINOR

This bill updates Louisiana's list of controlled substances by adding ten new synthetic opioids to the state's Schedule I. The changes convert the document from a draft proposal to an enrolled act, making these new substances legally prohibited under state law.

Scope change

The bill expands the scope of the Uniform Controlled Dangerous Substances Law to include specific new chemical compounds not previously listed.

REQUIREMENT

Added ten new substances to Schedule I of the Uniform Controlled Dangerous Substances Law, including N-Pyrrolidino protonitazene, Beta-Methylacetyl fentanyl, Para-Chlorofentanyl, Para-fluoro valeryl fentanyl, Tetrahydrothiofuranyl fentanyl, Ethyleneoxynitazene, 5-Methyl etodesnitazene, N,N-Dimethylamino etonitazene, N-Desethyl etonitazene, Methylenedioxynitazene, N-Pyrrolidino isotonitazene, and N-Desethyl protonitazene.

TECHNICAL

Changed the document status from 'ORIGINAL' draft to 'ENROLLED' Act No. 58, indicating the bill has been signed into law.

Reordered the list of controlled substances alphabetically and renumbered the entries to maintain consistency with the updated schedule.

Floor votes · Senate Apr 27, 2026 · House Mar 30, 2026

How they voted

36–0

Passed · 4 other

Total votes 40

Apr 27, 2026

D Democratic12

12 Yea

100% Yea

R Republican28

24 Yea 4

85% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 27, 2026

Upper · Passed

Read by title, passed by a vote of 36 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.

upper

Apr 15, 2026

Committee

Read by title and referred to the Legislative Bureau.

upper

Apr 14, 2026

Upper · Passed

Reported favorably.

upper

Mar 30, 2026

Lower · Passed

Read third time by title, roll called on final passage, yeas 97, nays 0. Finally passed, title adopted, ordered to the Senate.

lower

Mar 24, 2026

Lower · Passed

Reported favorably (12-0).

lower

Mar 9, 2026

Committee

Read by title, under the rules, referred to the Committee on Administration of Criminal Justice.

lower

Feb 13, 2026

Committee

Under the rules, provisionally referred to the Committee on Administration of Criminal Justice.

lower

1 primary · 0 co-sponsors